Evaluation of Cytokine Biomarkers in Melanoma Patients During Immunotherapy

Evaluation of Cytokine Biomarkers in Melanoma Patients During Immunotherapy

Publication date: Jun 16, 2021

Open prospective clinical trial to develop the computer software (Intelligent prognostic system) for predicting the efficacy of anti-PD-1 immunotherapy of melanoma patients in routine practice

Concepts Keywords
Biomarkers Medicine
Chemotherapy Branches of biology
Childbearing Clinical medicine
Routine Cancer immunotherapy
Weeks Melanoma
Biomarker
Radiation therapy
Radiation
Chemotherapy

Semantics

Type Source Name
pathway KEGG Breast cancer
disease MESH breast cancer
disease MESH cervical cancer
disease MESH malignancy
disease MESH pathology
pathway KEGG Melanoma
disease MESH Melanoma

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *